- 英文名称
- Paclitaxel Impurity 41
- 分子式
- C47H53NO15
- 分子量
- 871.92
- 中文别名
- 紫杉醇EP杂质M; 紫杉醇氧杂环丁烷开环3-乙酰基4-苯甲酰基杂质; 紫杉醇氧杂环丁烷开环3-乙酰基-4-苯甲酰杂质; 紫杉醇杂质M (EP); 紫杉醇杂质27; 紫杉醇杂质M; 紫杉醇杂质M1; (1S,3S,4AR,5S,6S,8S,11R,12AS)-8-(2R,3S)-3-苯甲酰胺基-2-羟基-3-苯丙酰基)氧基)-4-(苯甲酰氧基)甲基)-1,4,5,6-四羟基-9,12A,13,13-四甲基-12-氧基-1,2,3,4,4A,5,6,7,8,11,12,12A-十二氢-6,10-甲基苯并[10]环烯-3,11-二乙酸酯; Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl Impurity; β-(Benzoylamino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-Methanobenzocyclodecen-8-yl Ester; Paclitaxel Impurity 13（Paclitaxel EP Impurity M）; Paclitaxel EP Impurity M; 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20-tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate]; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl ester, (αR,βS)-; (1S,3S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl(αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate
- 用途
- 化学合成。
